Presentations

Documents

Order by : Name | Date | Hits | [ Descendent ]

Adipose tissue expandability, Lipotoxicity and the Metabolic Syndrome Adipose tissue expandability, Lipotoxicity and the Metabolic Syndrome

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 5.58 MB
Downloads: 1407

Oral presentation given by UCAM at the 19th European Congress of Endocrinology (ECE), Satellite Symposium (Aegerion Pharmaceuticals), Lisbon, Portugal, 20th - 23rd May 2017

Non-invasive biomarkers for NAFLD: Considerations for use in clinical practice & clinical trials Non-invasive biomarkers for NAFLD: Considerations for use in clinical practice & clinical trials

hot!
Date added: 11/01/2018
Date modified: 11/01/2018
Filesize: 256 Bytes
Downloads: 1407

Oral presentation given by UNEW at the Global NASH Congress, London, UK, 27th February 2018

Second Harmonic Generation: Fully Quantitative Histopathology Assessment for NASH Second Harmonic Generation: Fully Quantitative Histopathology Assessment for NASH

hot!
Date added: 07/29/2019
Date modified: 07/29/2019
Filesize: 256 Bytes
Downloads: 1424

Presentation given by UNEW at the NASH-TAG Conference, Deer Valley, Utah, USA, 5th January 2019

Fatty liver disease is associated to increased glucogenic amino acids and decreased de novo... Fatty liver disease is associated to increased glucogenic amino acids and decreased de novo...

hot!
Date added: 08/05/2018
Date modified: 08/05/2018
Filesize: 256 Bytes
Downloads: 1452

"Fatty liver disease is associated to increased glucogenic amino acids and decreased de novo alanine synthesis"

Oral presentation given by CNR & UNITO at the 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD 2017), Lisbon, Portugal, 15th September 2017

Systems approaches to study obesity and metabolic co-morbidities Systems approaches to study obesity and metabolic co-morbidities

hot!
Date added: 07/28/2018
Date modified: 07/28/2018
Filesize: 256 Bytes
Downloads: 1453

Oral presentation given by ORU at the 14th Key Symposium, Cambridge, UK, 20th September 2017

Development and Validation of the Collagen Neo-Epitope Biomarker Pro-C3 ‘FIB-C3 Score’ for... Development and Validation of the Collagen Neo-Epitope Biomarker Pro-C3 ‘FIB-C3 Score’ for...

hot!
Date added: 08/05/2018
Date modified: 08/05/2018
Filesize: 256 Bytes
Downloads: 1453

"Development and Validation of the Collagen Neo-Epitope Biomarker Pro-C3 ‘FIB-C3 Score’ for Detection and Staging of Advanced Non-Alcoholic Fatty Liver Disease in a Large International Multi-Centre Patient Cohort"

Oral presentation given by UNEW, ICAN, UNITO, UMC & NB at the 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Washington DC, USA, 20th - 24th October 2017

Genetic Testing: Any Utility in Sub-Phenotyping or Risk Stratification in Clinical Trials Genetic Testing: Any Utility in Sub-Phenotyping or Risk Stratification in Clinical Trials

hot!
Date added: 07/29/2019
Date modified: 07/29/2019
Filesize: 256 Bytes
Downloads: 1467

Presentation given by UNEW at the NASH-TAG Conference, Deer Valley, Utah, USA, 5th January 2019

Body fat distribution, insulin resistance and NASH Body fat distribution, insulin resistance and NASH

hot!
Date added: 08/05/2018
Date modified: 08/05/2018
Filesize: 8.89 MB
Downloads: 1491

Oral presentation given by CNR at the Meeting Quadrisocietario Diabesità (SICOB, SID, SIE, SIO), Pisa, Italy, 5th - 6th October 2017

Development and Validation of the Collagen Neo-Epitope Biomarker Pro-C3 ‘FIB-C3 Score’ for Detection Development and Validation of the Collagen Neo-Epitope Biomarker Pro-C3 ‘FIB-C3 Score’ for Detection

hot!
Date added: 07/28/2018
Date modified: 07/28/2018
Filesize: 256 Bytes
Downloads: 1494

"Development and Validation of the Collagen Neo-Epitope Biomarker Pro-C3 ‘FIB-C3 Score’ for Detection and Staging of Advanced Non-Alcoholic Fatty Liver Disease in a Large International Multi-Centre Patient Cohort"

Oral presentation given by UNEW, ICAN, UMC, UNITO & NB at the BASL Annual Meeting, Coventry, UK, 20th September 2017

How to manage HCV patients with SVR response who do not regress How to manage HCV patients with SVR response who do not regress

hot!
Date added: 07/29/2019
Date modified: 07/29/2019
Filesize: 256 Bytes
Downloads: 1505

Presentation given by UMC at the Taiwanese Association for the Study of the Liver (TASL) meeting, Taichung, Taiwan, 8th - 9th December 2018